ELUT FY 2023 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$25M+3.8% YoY

Gross Profit

$11M44.7% margin

Operating Income

-$31M-123.4% margin

Net Income

-$38M-152.2% margin

EPS (Diluted)

$-2.07

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$43M

Total Liabilities

$82M

Stockholders' Equity

-$39M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$24M	+3.8%
Gross Profit	$11M	$12M	-5.0%
Operating Income	-$31M	-$35M	+13.3%
Net Income	-$38M	-$33M	-14.5%